• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Ignyte Acquisition Corp. (Amendment)

    1/26/22 5:25:46 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials
    Get the next $IGNY alert in real time by email
    SC 13G/A 1 IGNY_13GA2_20220126.htm

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    Schedule 13G/A

    (Rule 13d-102)

    Amendment No. 2

     

    Under the Securities Exchange Act of 1934

     

    IGNYTE ACQUISITION CORP

    (Name of Issuer)

     

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

     

    45175H106

    (CUSIP Number)

     

    January 25, 2022

    (Date of Event which Requires Filing of this Statement)

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

     

    Rule 13d-1(b)¨
    Rule 13d-1(c)x
    Rule 13d-1(d)¨

     

    *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

     

     

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

    (Continued on following pages)

    (Page 1 of 12 Pages)

     

     
     

     

    CUSIP No.  45175H106 Schedule 13G/A Page 2 of 12 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    THE K2 Principal Fund, L.P.

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Ontario, CANADA

    NUMBER OF SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

       -0-

    6

    SHARED VOTING POWER

        259,958

    7

    SOLE DISPOSITIVE POWER

       -0-

    8

    SHARED DISPOSITIVE POWER

     259,958

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        259,958

     
    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.57%

    12

    TYPE OF REPORTING PERSON

    PN

     

      

     
     
    CUSIP No.  45175H106 Schedule 13G/A Page 3 of 12 Pages

      

    1

    NAME OF REPORTING PERSONS

     

    K2 Genpar 2017 Inc.

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Ontario, CANADA

    NUMBER OF SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

       -0-

    6

    SHARED VOTING POWER

        259,958

    7

    SOLE DISPOSITIVE POWER

       -0-

    8

    SHARED DISPOSITIVE POWER

     259,958

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

        259,958

     
    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.57%

    12

    TYPE OF REPORTING PERSON

    CO

     

     
     
    CUSIP No.  45175H106 Schedule 13G/A Page 4 of 12 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    SHAWN KIMEL INVESTMENTS, INC.

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ONTARIO, CANADA

    NUMBER OF SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

       -0-

    6

    SHARED VOTING POWER

        259,958

    7

    SOLE DISPOSITIVE POWER

       -0-

    8

    SHARED DISPOSITIVE POWER

        259,958

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

       259,958

     
    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.57%

    12

    TYPE OF REPORTING PERSON

    CO

     

     
     
    CUSIP No.  45175H106 Schedule 13G/A Page 5 of 12 Pages

     

    1

    NAME OF REPORTING PERSONS

     

    K2 & ASSOCIATES INVESTMENT MANAGEMENT INC.

     
    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
     
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    ONTARIO, CANADA

    NUMBER OF SHARES

    BENEFICIALLY

    OWNED BY

    EACH REPORTING

    PERSON WITH

    5

    SOLE VOTING POWER

       -0-

    6

    SHARED VOTING POWER

        259,958

    7

    SOLE DISPOSITIVE POWER

       -0-

    8

    SHARED DISPOSITIVE POWER

        259,958

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

       259,958

     
    10

    CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

    ¨

    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    3.57%

    12

    TYPE OF REPORTING PERSON

    CO

      

     
     
    CUSIP No.  45175H106 Schedule 13G/A Page 6 of 12 Pages

      

    Item 1(a).Name of Issuer:

     

    The name of the issuer is IGNYTE ACQUISITION CORP

     

    Item 1(b).Address of Issuer's Principal Executive Offices:

     

    The Company's principal executive offices are located at 650 Fifth Avenue, 4th Floor New York, NY 10019

     

    Item 2(a).Name of Person Filing:

     

    The persons filing this statement are Shawn Kimel Investments, Inc., an Ontario corporation (“SKI“), The K2 Principal Fund, L.P., an Ontario limited partnership (the “Fund“), K2 Genpar 2017 Inc., an Ontario corporation and the General Partner to the Fund (“Genpar 2017“), and K2 & Associates Investment Management Inc., an Ontario corporation (“K2 & Associates“). Together SKI, the Fund, Genpar2017, and K2 & Associates are the “Reporting Persons“).

     

    Mr. Gosselin is Vice president of SKI, Secretary of Genpar 2017, and President of K2 & Associates. K2 & Associates is a direct 66.5% owned subsidiary of SKI, and is the investment manager of the Fund

     

    Item 2(b).Address of Principal Business Office or, if None, Residence:

     

    The address of the principal business office of each of the Reporting Persons is 2 Bloor St West, Suite 801, Toronto, Ontario, M4W 3E2

     

    Item 2(c).Citizenship:

     

    Mr. Gosselin is a citizen of Canada.

     

    The Fund is an Ontario limited partnership.

     

    Each of SKI and GenPar 2017 Inc and K2 & Associates is an Ontario corporation.

     

    Item 2(d).Title of Class of Securities:

     

    Common Stock, par value $0.0001 per share

     

    Item 2(e).CUSIP Number:

     

    45175H106

     

     
    CUSIP No.  45175H106 Schedule 13G/A Page 7 of 12 Pages

      

    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:

     

    (a)¨   Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);

     

    (b)¨   Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);

     

    (c)¨   Insurance company defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);

     

    (d)¨   Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);

     

    (e)¨   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);

     

    (f)¨     An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);

     

    (g)¨    A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);

     

    (h)¨    A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

    (i)¨    A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

    (j)¨    A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J);

     

    (k)¨    Group, in accordance with § 240.13d-1(b)(1)(ii)(K).

     

    If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:________________.

     

     
     
    CUSIP No.  45175H106 Schedule 13G/A Page 8 of 12 Pages

      

    Item 4. Ownership:

     

    Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

     

    The K2 Principal Fund, L.P.

     

    (a) Amount beneficially owned: 259,958
    (b) Percent of class: 3.57%
    (c) Number of shares as to which the person has:

      (i)   Sole power to vote or direct the vote: 0
      (ii)   Shared power to vote or direct the vote: 259,958
      (iii)   Sole power to dispose or direct the disposition of: 0
      (iv)   Shared power to dispose or direct the disposition of: 259,958

     

    K2 Genpar 2017 Inc.

     

    (a) Amount beneficially owned: 259,958
    (b) Percent of class: 3.57%
    (c) Number of shares as to which the person has:

      (i) Sole power to vote or direct the vote: 0
      (ii) Shared power to vote or direct the vote: 259,958
      (iii) Sole power to dispose or direct the disposition of: 0
      (iv) Shared power to dispose or direct the disposition of: 259,958

     

    SHAWN KIMEL INVESTMENTS, INC.

     

    (a) Amount beneficially owned: 259,958
    (b) Percent of class: 3.57%
    (c) Number of shares as to which the person has:

      (i) Sole power to vote or direct the vote: 0
      (ii) Shared power to vote or direct the vote: 259,958
      (iii) Sole power to dispose or direct the disposition of: 0
      (iv) Shared power to dispose or direct the disposition of: 259,958

     

     

     
    CUSIP No.  45175H106 Schedule 13G/A Page 9 of 12 Pages

      

    K2 & Associates Investment Management Inc..

     

    (a) Amount beneficially owned: 259,958
    (b) Percent of class: 3.57%
    (c) Number of shares as to which the person has:

      (i) Sole power to vote or direct the vote: 0
      (ii) Shared power to vote or direct the vote: 259,958
      (iii) Sole power to dispose or direct the disposition of: 0
      (iv) Shared power to dispose or direct the disposition of: 259,958

     

    259,958 Common Stock, par value $0.0001 per share held of record (and may be deemed to be beneficially owned) by The K2 Principal Fund, L.P. See Item 2(a) above for a description of the corporate structure of the Reporting Persons. Each of the Reporting Persons may be deemed to be beneficial owners of the 259,958 shares of the Issuer's Common Stock, par value $0.0001 per share that are held by The K2 Principal Fund, L.P. Mr. Daniel Gosselin is vice president of SKI, Secretray of GenPar 2017 and President of K2 & ASSOCIATES, and exercises ultimate voting and investment powers over the 259,958 shares of the Issuer's Units that are held of record by The K2 Principal Fund, L.P

     

    The percentages used in this Schedule 13G/A are calculated based upon 7,287,500 ordinary shares issued and outstanding as of November 12, 2021, as reported in the companies 10Q filed with the SEC on November 15, 2021.

     

    Item 5.         Ownership of Five Percent or Less of a Class.

     

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following [X]

     

    Item 6.         Ownership of More Than Five Percent on Behalf of Another Person.

     

    Not applicable.

     

    Item 7.         Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.

     

    Not applicable.

     

    Item 8.         Identification and Classification of Members of the Group.

     

    Not applicable.

     

     
     

     

    CUSIP No.  45175H106 Schedule 13G/A Page 10 of 12 Pages

     

    Item 9.         Notice of Dissolution of Group.

     

    Not applicable.

     

    Item 10.        Certification.

     

    Each of the Reporting Persons hereby makes the following certification:

    By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     
     

     

    CUSIP No.  45175H106 Schedule 13G/A Page 11 of 12 Pages

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

     

    Dated: January 26, 2022

      THE K2 PRINCIPAL FUND, L.P.
         
      By: K2 Genpar 2017 Inc., its General Partner
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        Secretary
         
         
      K2 Genpar 2017 Inc.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        Secretary
         
      SHAWN KIMEL INVESTMENTS, INC.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        President
         
         
      /s/ Daniel Gosselin
      K2 & ASSOCIATES INVESTMENT MANAGEMENT INC.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        President
         

    The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative (other than an executive officer or general partner of this filing person), evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature.

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

     

    CUSIP No.  45175H106 Schedule 13G/A Page 12 of 12 Pages

     

    Exhibit 1

     

    JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)

     

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G/A is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G/A shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

     

    Date: January 26, 2022

      THE K2 PRINCIPAL FUND, L.P.
         
      By: K2 Genpar 2017 Inc., its General Partner
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        Secretary
         
         
      K2 Genpar 2017 Inc.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        Secretary
         
      SHAWN KIMEL INVESTMENTS, INC.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        Vice President
         
         
      K2 & ASSOCIATES INVESTMENT MANAGEMENT INC.
         
      By: /s/ Daniel Gosselin
        Daniel Gosselin
        President
         
         
    Get the next $IGNY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IGNY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IGNY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Peak Bio Co., Ltd. to List on NASDAQ Following Successful Business Combination with Ignyte Acquisition Corp.

    Combined Company Scheduled to Commence Trading on NASDAQ Under the Ticker Symbol "PKBO" Peak Bio Co., Ltd. ("Peak Bio"), a clinical-stage biopharmaceutical company focused on developing the next-generation of therapeutics to treat oncology and inflammatory diseases, today announced the completion of its business combination (the "Business Combination") with Ignyte Acquisition Corp. (NASDAQ:IGNY) ("Ignyte"), a special purpose acquisition company. The transaction was approved at a special meeting of Ignyte's stockholders held on October 25, 2022 (the "Special Meeting"). Ignyte's stockholders also voted to approve all other proposals presented at the Special Meeting. Ignyte's Board of Direct

    11/2/22 7:30:00 AM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    Ignyte Acquisition Corp. Stockholders Approve Proposed Business Combination with Peak Bio

    Transaction Expected to Close on October 31, 2022 Ignyte Acquisition Corp. ("Ignyte") (NASDAQ:IGNY), a publicly traded special purpose acquisition company, today announced that Ignyte's stockholders have approved its proposed business combination (the "Business Combination") with Peak Bio Co., Ltd. ("Peak Bio") at a Special Meeting of its stockholders held on October 25, 2022 (the "Special Meeting"). The Special Meeting to be held on October 31, 2022 has been canceled. Approximately 75% of the votes cast at the Special Meeting, representing approximately 75% of Ignyte's outstanding shares of common stock entitled to vote at the Special Meeting, were cast in favor of the proposal to approv

    10/27/22 8:05:00 AM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company

    - Company to be led by Hoyoung Huh, M.D. Ph.D., serial entrepreneur / investor with notable public and private biotech board positions - $25 million private investment in public equity ("PIPE") with participation from leading healthcare institutional investor, Palo Alto Investors (PAI) with additional participation from Peak Bio's CEO, Hoyoung Huh, MD, Ph.D. - Differentiated pipeline includes next generation Neutrophil Elastase Inhibitor targeting AATD / ARDS and robust preclinical ADC oncology platform utilizing Antibody Drug Conjugates - Anticipated cash at closing expected to fully fund the company through 2024 allowing for multiple milestones in ADC program and interim Phase II for A

    4/28/22 4:32:00 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    $IGNY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lamond Stephen J bought 5,600 shares, increasing direct ownership by 39% to 19,850 units (SEC Form 4)

    4 - Peak Bio, Inc. (0001834645) (Issuer)

    9/28/23 4:05:23 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    Lamond Stephen J bought 14,250 shares (SEC Form 4) (Amendment)

    4/A - Peak Bio, Inc. (0001834645) (Issuer)

    9/28/23 4:05:04 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Huh Hoyoung bought 45,000 shares, increasing direct ownership by 0.54% to 8,382,742 units

    4 - Peak Bio, Inc. (0001834645) (Issuer)

    9/25/23 4:05:03 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    $IGNY
    SEC Filings

    View All

    SEC Form 8-K filed by Ignyte Acquisition Corp.

    8-K - Peak Bio, Inc. (0001834645) (Filer)

    2/6/24 4:09:01 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    SEC Form 8-K filed by Ignyte Acquisition Corp.

    8-K - Peak Bio, Inc. (0001834645) (Filer)

    1/29/24 5:08:05 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    Ignyte Acquisition Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities

    8-K - Peak Bio, Inc. (0001834645) (Filer)

    1/3/24 5:08:00 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    $IGNY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Lamond Stephen J bought 5,600 shares, increasing direct ownership by 39% to 19,850 units (SEC Form 4)

    4 - Peak Bio, Inc. (0001834645) (Issuer)

    9/28/23 4:05:23 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    Lamond Stephen J bought 14,250 shares (SEC Form 4) (Amendment)

    4/A - Peak Bio, Inc. (0001834645) (Issuer)

    9/28/23 4:05:04 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    SEC Form 4: Huh Hoyoung bought 45,000 shares, increasing direct ownership by 0.54% to 8,382,742 units

    4 - Peak Bio, Inc. (0001834645) (Issuer)

    9/25/23 4:05:03 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    $IGNY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D filed by Ignyte Acquisition Corp.

    SC 13D - Peak Bio, Inc. (0001834645) (Subject)

    3/21/23 5:30:30 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G filed by Ignyte Acquisition Corp.

    SC 13G - Peak Bio, Inc. (0001834645) (Subject)

    2/28/23 4:01:06 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    SEC Form SC 13G/A filed by Ignyte Acquisition Corp. (Amendment)

    SC 13G/A - Peak Bio, Inc. (0001834645) (Subject)

    2/14/23 3:39:04 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials

    $IGNY
    Financials

    Live finance-specific insights

    View All

    Peak Bio and Ignyte Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Oncology and Inflammation Company

    - Company to be led by Hoyoung Huh, M.D. Ph.D., serial entrepreneur / investor with notable public and private biotech board positions - $25 million private investment in public equity ("PIPE") with participation from leading healthcare institutional investor, Palo Alto Investors (PAI) with additional participation from Peak Bio's CEO, Hoyoung Huh, MD, Ph.D. - Differentiated pipeline includes next generation Neutrophil Elastase Inhibitor targeting AATD / ARDS and robust preclinical ADC oncology platform utilizing Antibody Drug Conjugates - Anticipated cash at closing expected to fully fund the company through 2024 allowing for multiple milestones in ADC program and interim Phase II for A

    4/28/22 4:32:00 PM ET
    $IGNY
    Consumer Electronics/Appliances
    Industrials